Related Experiment Video
Updated: Jul 10, 2026

Manufacturing Chimeric Antigen Receptor (CAR) T Cells for Adoptive Immunotherapy
Published on: December 17, 2019
Emerging therapy for chronic lymphocytic leukaemia.
Rebecca L Auer1, John Gribben, Finbarr E Cotter
1Centre for Haematology, Barts and the London School of Medicine, London, UK. r.l.auer@qmul.ac.uk
Chronic lymphocytic leukaemia (CLL) treatment varies due to diverse disease presentations. Combination chemotherapy improves prognosis, while novel agents and stem cell transplantation are emerging as promising therapeutic options.
Area of Science:
- Hematology
- Oncology
- Immunology
Background:
- Chronic lymphocytic leukaemia (CLL) exhibits diverse clinical presentations and prognoses.
- Treatment strategies for CLL are tailored to disease variability.
- Disease staging and molecular markers aid in risk stratification.
Purpose of the Study:
- To review current and emerging therapeutic strategies for chronic lymphocytic leukaemia (CLL).
- To discuss the role of chemotherapy, novel agents, and stem cell transplantation in CLL management.
- To highlight the importance of understanding disease biology and prognostic indicators.
Main Methods:
- Review of existing literature on CLL treatment modalities.
- Analysis of the efficacy of chemotherapy, novel agents, and allogeneic stem cell transplantation.
- Discussion of prognostic markers including cytogenetics, molecular status, CD38, and ZAP-70.
Main Results:
- Combination chemotherapy using nucleoside analogues and alkylating agents has improved CLL prognosis.
- Novel agents are being investigated for improved therapeutic outcomes in CLL.
- Allogeneic stem cell transplantation represents a potential cure for CLL.
Conclusions:
- CLL management requires personalized approaches based on disease characteristics.
- Ongoing clinical trials are crucial to define the optimal role of novel therapies and stem cell transplantation.
- Integrating knowledge of CLL biology and prognostic markers is essential for advancing treatment.
More Related Videos
09:02Immunoglobulin Gene Sequence Analysis In Chronic Lymphocytic Leukemia: From Patient Material To Sequence Interpretation
Published on: November 26, 2018
06:08Assessment of Chimeric Antigen Receptor T Cell-Associated Toxicities Using an Acute Lymphoblastic Leukemia Patient-Derived Xenograft Mouse Model
Published on: February 10, 2023
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Treatment Resistent Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...